Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut - Wikidata - wikimedia - TriplyDB

Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut

Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut

http://www.wikidata.org/entity/Q37097658

about

Effect of probiotics on central nervous system functions in animals and humans - a systematic review Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier Individualized medicine and the microbiome in reproductive tract The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis The Microbiome and Sustainable Healthcare.Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups.Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters.Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review The effects of gut microbiota on CNS function in humans.Recommendations for probiotic use in humans-a 2014 update Probiotic Bifidobacterium species stimulate human SLC26A3 gene function and expression in intestinal epithelial cells.The microbiome: stress, health and disease.Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase.Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis.Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons.Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study.Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.Immune-to-Brain Communication Pathways in Inflammation-Associated Sickness and Depression.Perioperative supplementation with bifidobacteria improves postoperative nutritional recovery, inflammatory response, and fecal microbiota in patients undergoing colorectal surgery: a prospective, randomized clinical trial.Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial.The Surface-Associated Exopolysaccharide of Bifidobacterium longum 35624 Plays an Essential Role in Dampening Host Proinflammatory Responses and Repressing Local TH17 Responses.Probiotics, Prebiotics, and Synbiotics for the Treatment and Prevention of Adult Dermatological Diseases.Host-derived glycans serve as selected nutrients for the gut microbe: human milk oligosaccharides and bifidobacteria.Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes.Metabolite and Microbiome Interplay in Cancer Immunotherapy Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators.Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases.Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases.The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE.Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model.Probiotics: a proactive approach to health. A symposium report.Bifidobacteria and Their Molecular Communication with the Immune System.The Role of the Skin and Gut Microbiome in Psoriatic Disease.The gut-skin axis in health and disease: A paradigm with therapeutic implications.Microbiome and asthma.Genetic engineering as a powerful tool to improve probiotic strains.

P2860

Q26740447-D0EB7DC6-A359-4348-9075-4F7785AC7853 Q26825483-1D5FDC80-8F59-4CEF-A1C8-471E8FEC651B Q26999090-4EDD4221-DA1A-41BF-A9DC-341993BE2F6C Q27001546-8FD967D9-FFD1-4351-802F-EA54CF6F64E6 Q27001712-2668460A-0B18-4C19-9F91-FCE145674504 Q28088606-F1A3E36C-2408-482E-93C3-796FF18A6A4D Q28554290-07309675-10BD-4666-90BB-29D7455417FA Q30575382-D3EA8E9C-8334-4D01-B004-6583389E89AA Q33649866-64B93089-D665-468D-BF56-5DF2C2CD82F4 Q33776463-44DD7D10-2A14-4210-9239-717CD5CAA5B5 Q34129414-47375CF6-A534-46C8-B048-05177282EAC2 Q34411373-F0BB54CB-F5CD-44FC-9521-80C70A589C55 Q34726615-B6B72EA2-05B5-414C-B8FE-BD265C1DE7D7 Q35054658-09436984-004D-4E68-B0C0-6831F5DC0EFD Q35105814-AA32FD86-C052-49DF-A8FC-DEAB5B81810E Q35625435-795CA3AC-F3DA-4DAF-9694-2D3AF826A89F Q35720420-B1635333-E08E-4BE3-9C67-0050482CC0D1 Q35896707-B2075EE5-0359-457E-AB91-29B96BE89B6A Q36028377-5A4E997F-1C1A-40DB-81DB-42FDE5D18360 Q36060516-CEDA52BA-D523-4DA3-9583-C0775A823DBC Q36146367-2231484A-BF95-4D5F-A32E-EF4588EA63E9 Q36875919-A179CC82-1F47-453F-886D-E172BBA7876B Q37050763-1980D654-692D-4AEA-A9E6-FB2F98CEDBF3 Q37428485-20A9EBB4-78EC-41E9-A412-9F4B993B646D Q38691786-0B39AE75-8B3F-465B-8E6C-0A3B05776B2B Q38720798-E418F3A8-19A0-4DF7-8D5D-F09940ED9624 Q38754711-0B0170D9-316C-4B46-A1FE-0EDCDE7B430C Q38800832-C59D6D7D-C982-4F7D-8A8A-AF10CFA74E6C Q38899859-1856BB31-F046-4DE5-AD63-ECE4B6B21E1A Q39127400-AC978427-36C9-4F6A-806F-D4548E9F356F Q39336917-58644334-11BC-4C83-A3AB-0AE9A8CF3E7A Q39435551-CD17216C-9DB6-438B-92CE-77B1A4776461 Q39455595-BDA391A5-7E97-477C-91B2-D4AC69701B0C Q41659643-A1DEBAE8-6DF5-4B47-929B-1A8BAF4D5856 Q43594513-9C836770-735B-43B2-B644-D128B6D1ABDC Q46237028-A872728A-3E9F-4AF6-AB03-48FECE526ACA Q46383713-B2ABC000-E694-4049-81C1-A0D9828456D8 Q46471309-18EFBB6B-FA67-4619-A017-9DDC13D750D7 Q47228960-7DD12D11-F8C4-4464-ACF6-CA6929F854C8 Q47296777-5F54C9D1-76E1-488B-B3B9-DBDD5ECF2E51

P2860

Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut

http://www.wikidata.org/entity/Q37097658

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut

@en

Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut.

@nl

type

label

Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut

@en

Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut.

@nl

prefLabel

Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut

@en

Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut.

@nl

P1433

Q37097658-6843E256-2658-443E-84E4-0FBDC214C86C

P1476

Q37097658-778726EC-B94D-44B9-9F9A-25EF059A9F5D

P2093

Q37097658-3B122196-394F-46B7-BF08-05F4FC197E30

Q37097658-7DF217CA-EC3E-4A1A-B335-5D1B3CC01F61

Q37097658-977F8C05-0E41-4B8D-B4AA-1D9262FC0496

Q37097658-AFBD968F-5340-49D6-A0EA-1D2D07C87809

Q37097658-B1E86C4C-D531-4C69-AEF1-F0E750C0628D

Q37097658-BA3ED2CB-7E64-4A0D-AAA0-277FFFD36BCB

Q37097658-E92E961F-2C7D-4725-89C5-5E384AB992C4

Q37097658-F6EB1246-A3B6-4F6E-AA81-C7FA04BA8C7C

P2860

Q37097658-03935022-EB54-4A09-BB8B-A0FA0BF0968E

Q37097658-0A20BE2D-B328-4235-B992-7196BF1E6BDB

Q37097658-0E1FAD61-1A09-4922-B637-A76F8E55730D

Q37097658-130C5FB2-7A38-4D8C-B964-B1A2C35F5E52

Q37097658-18C81BFB-C8C8-4620-9BD9-40603631CED3

Q37097658-1E8E3E56-4575-4506-B4DE-FF28A0321863

Q37097658-258BB1DC-EE4B-41BC-A373-FBED6D44ECF0

Q37097658-25CF11A0-9A3B-47D7-888B-591FBC466E5B

Q37097658-280D1377-FAD6-432A-868D-D259BBA255E6

Q37097658-28C2A956-2BF3-4122-809E-860610831F10

P304

Q37097658-B86FF9A3-3FBD-4150-A045-685589541028

P31

Q37097658-0FB672B0-2BC7-4871-8560-F9C592FEDDAF

P356

Q37097658-9D085512-F1BE-4D0C-B20F-A8AA255E8EA7

P433

Q37097658-8DB82859-157B-4D16-B8FC-CC43B9B63B47

P478

Q37097658-A795D257-2295-45AD-BEDE-638FD3B49C24

P577

Q37097658-D6BC750D-40E9-4C52-8209-D6FE3D31C87B

P5875

Q37097658-AEE8C544-A709-405F-81F5-459D5693B785

P698

Q37097658-E261195E-6E3D-4787-82B7-E81BB3184010

P921

Q37097658-DDCEB958-E9E1-4187-8533-04B71DBAE16B

P932

Q37097658-BF99607D-0B08-4CCD-9627-0310100C1111

P356

P1433

P1476

Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut

@en

P2093

Barry Kiely

http://www.w3.org/2001/XMLSchema#string

David Groeger

http://www.w3.org/2001/XMLSchema#string

Eamonn M M Quigley

http://www.w3.org/2001/XMLSchema#string

Eileen F Murphy

http://www.w3.org/2001/XMLSchema#string

Fergus Shanahan

http://www.w3.org/2001/XMLSchema#string

John F Bourke

http://www.w3.org/2001/XMLSchema#string

Liam O'Mahony

http://www.w3.org/2001/XMLSchema#string

Timothy G Dinan

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis and inflammation in the intestine

C-reactive protein: a critical update

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

Induction of colonic regulatory T cells by indigenous Clostridium species

Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis.

Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation.

APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample.

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

P304

325-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/GMIC.25487

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248396255

http://www.w3.org/2001/XMLSchema#string

P698

23842110

http://www.w3.org/2001/XMLSchema#string

P921

P932

3744517

http://www.w3.org/2001/XMLSchema#string